Pancreatic Cancer Research

ResearcherFred Hutch Cancer CenterNo recent work listed

Darren S. Sigal

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-7839-1230; OpenAlex author ID A5000933337. Sources: ClinicalTrials.gov.

Their work

Papers
5 (first author 0, last author 2)
Trials
1 (principal investigator on 1)
Grants
0
Labs led
0
Collaborators
36
Papers, trials and grants by year

2015: 1 paper · 2016: none · 2017: 1 trial · 2018: 1 paper · 2019: none · 2020: 1 paper · 2021: none · 2022: none · 2023: 2 papers

Papers 5

  1. Neoadjuvant chemotherapy and radiotherapy outcomes in borderline-resectable and locally-advanced pancreatic cancer patients. Last author DOI 10.1002/cam4.5523↗
  2. Do patients with metastatic pancreatic adenocarcinoma to the lung have improved survival? Last author DOI 10.1002/cam4.5751↗
  3. Randomized Phase III Trial of Pegvorhyaluronidase Alfa With Nab-Paclitaxel Plus Gemcitabine for Patients With Hyaluronan-High Metastatic Pancreatic Adenocarcin… Co-author DOI 10.1200/jco.20.00590↗
  4. HALO 202: Randomized Phase II Study of PEGPH20 Plus Nab-Paclitaxel/Gemcitabine Versus Nab-Paclitaxel/Gemcitabine in Patients With Untreated, Metastatic Pancrea… Co-author DOI 10.1200/jco.2017.74.9564↗
  5. Randomized Phase II Trial of Gemcitabine Plus TH-302 Versus Gemcitabine in Patients With Advanced Pancreatic Cancer. Co-author DOI 10.1200/jco.2014.55.7504↗

Trials 1

  1. PEGPH20 Plus Gemcitabine With Radiotherapy in Patients With Localized, Unresectable Pancreatic Cancer Principal investigator NCT02910882↗

Closest collaborators

The 25 strongest of 36 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Aren Ebrahimi · 1 shared paper, 2023 · strength 0.20
  2. Jason Cham · 1 shared paper, 2023 · strength 0.20
  3. Gregory P. Botta · 1 shared paper, 2023 · strength 0.20
  4. Nathan Bahary · 3 shared papers, 2015–2020 · strength 0.18
  5. Andrea J. Bullock · 2 shared papers, 2018–2020 · strength 0.14
  6. Andrew Eugene Hendifar · 2 shared papers, 2018–2020 · strength 0.14
  7. Lei Zheng · 2 shared papers, 2018–2020 · strength 0.14
  8. Sunil R. Hingorani · 2 shared papers, 2018–2020 · strength 0.14
  9. Paul E. Oberstein · 2 shared papers, 2018–2020 · strength 0.14
  10. Susan Elaine Bates · 1 shared paper, 2020 · strength 0.08
  11. Fabienne Portales · 1 shared paper, 2020 · strength 0.08
  12. Do‐Youn Oh · 1 shared paper, 2020 · strength 0.08
  13. Christelle de la Fouchardière · 1 shared paper, 2020 · strength 0.08
  14. Anthony Maraveyas · 1 shared paper, 2020 · strength 0.08
  15. Volker Heinemann · 1 shared paper, 2020 · strength 0.08
  16. Anup Kasi · 1 shared paper, 2020 · strength 0.08
  17. Chung‐Pin Li · 1 shared paper, 2020 · strength 0.08
  18. Nicola Fazio · 1 shared paper, 2020 · strength 0.08
  19. Jill Lacy · 1 shared paper, 2020 · strength 0.08
  20. Joon Oh Park · 1 shared paper, 2020 · strength 0.08
  21. Vaibhav Sahai · 1 shared paper, 2020 · strength 0.08
  22. Pascal R. Hammel · 1 shared paper, 2020 · strength 0.08
  23. Margaret A. Tempero · 1 shared paper, 2020 · strength 0.08
  24. Eric Van Cutsem · 1 shared paper, 2020 · strength 0.08
  25. Teresa Mercade Macarulla · 1 shared paper, 2020 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.